Author:
Hanauske Axel-Rainer,Eismann Ulrike,Oberschmidt Olaf,Pospisil Heike,Hoffmann Steve,Hanauske-Abel Hartmut,Ma Doreen,Chen Victor,Paoletti Paolo,Niyikiza Clet
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference29 articles.
1. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636–2644
2. Hanna N, Shepherd FA, Fossella FV, et al. (2004) Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 22:1589–1597
3. Shih C, Habeck LL, Mendelsohn LG, et al. (1998) Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidin-based antifolate LY231514 (MTA). Adv Enzyme Regul 38:135–52
4. Westerhof GR, Schornagel JH, Kathmann I, Jackman AL, Rosowsky A, Forsch RA, Hynes JB, Boyle FT, Peters GJ, Pinedo HM, et al. (1995) Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity. Mol Pharmacol 48(3):459–471
5. Habeck LL, Mendelsohn LG, Shih C, Taylor EC, Colman PD, Gossett LS, Leitner TA, Schultz RM, Andis SL, Moran RG (1995) Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs. Mol Pharmacol 48(2):326–333
Cited by
77 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献